Fertility Clock Headlines, Fertility Headlines

SOFT Yields Hard Data on Hormone Therapy

For decades, we have been wondering whether suppression of the ovaries in addition to tamoxifen would improve the outcomes of women with hormone-receptor–positive premenopausal breast cancer. The SOFT trial was designed to address that question on the basis of a lot of data that suggested that it might help, especially in very young women.

Leave a Reply

Your email address will not be published. Required fields are marked *